[1]
|
Paraskevas, K.I. and Sillesen, H.H. (2020) Carotid Atherosclerosis Markers and Adverse Cardiovascular Events. Inter-national Journal of Cardiology, 307, 178. https://doi.org/10.1016/j.ijcard.2019.10.047
|
[2]
|
孙蔚, 王慧丽, 岳媛媛, 等. 血清炎症因子白细胞介素-18、高敏C反应蛋白、肿瘤坏死因子-α与2型糖尿病患者颈动脉粥样硬化的关系[J]. 临床内科杂志, 2023, 40(4): 265-267.
|
[3]
|
Goikuria, H., Vandenbroeck, K. and Alloza, I. (2018) Inflamma-tion in Human Carotid Atheroma Plaques. Cytokine & Growth Factor Reviews, 39, 62-70. https://doi.org/10.1016/j.cytogfr.2018.01.006
|
[4]
|
钟子安, 刘娟, 杨柳, 等. 基于Nox4/NLRP3通路探讨桃叶珊瑚苷干预动脉粥样硬化的作用机制[J]. 中西医结合心脑血管病杂志, 2023, 21(13): 2405-2411.
|
[5]
|
van Leent, M.M.T., Beldman, T.J., Toner, Y.C., et al. (2021) Prosaposin Mediates Inflammation in Atherosclerosis. Science Trans-lational Medicine, 13, eabe1433. https://doi.org/10.1126/scitranslmed.abe1433
|
[6]
|
颜因, 刘多, 李承, 等. 急性脑梗死患者血管内皮功能、Hcy水平及预后分析[J]. 实用临床医药杂志, 2016, 20(9): 10-13.
|
[7]
|
邓远琼, 刘伯胜, 邓远琪, 等. 急性脑梗死患者血管内皮功能和同型半胱氨酸水平变化及其治疗[J]. 中国全科医学, 2013, 16(32): 3057-3061.
|
[8]
|
Esse, R., Barroso, M., Tavares de Almeida, I. and Castro, R. (2019) The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art. International Journal of Molecular Sciences, 20, Article 867.
https://doi.org/10.3390/ijms20040867
|
[9]
|
Fittipaldi, S., Pini, R., Pasquinelli, G., et al. (2016) High Sensitivity C-Reactive Protein and Vascular Endothelial Growth Factor as Indicators of Carotid Plaque Vulnerability. The Journal of Cardiovascular Surgery, 57, 861-871.
|
[10]
|
Umemura, T., Kawamura, T., Mashita, S., et al. (2016) Higher Levels of Cystatin C Are Associated with Extracranial Carotid Artery Steno-Occlusive Disease in Patients with Noncardioembolic Ischemic Stroke. Cerebrovascular Diseases Extra, 6, 1-11. https://doi.org/10.1159/000443338
|
[11]
|
Chen, A., Wu, W., Gong, J., et al. (2023) Association of Homocysteine with Carotid Atherosclerosis in Hypertension. Journal of Hu-man Hypertension, 37, 227-234. https://doi.org/10.1038/s41371-022-00665-1
|
[12]
|
Catena, C., Colussi, G., Url-Michitsch, M., et al. (2015) Subclinical Carotid Artery Disease and Plasma Homocysteine Levels in Patients with Hypertension. Journal of the American Society of Hypertension, 9, 167-175.
https://doi.org/10.1016/j.jash.2014.12.020
|
[13]
|
Piazzolla, G., Candigliota, M., Fanelli, M., et al. (2019) Hyperho-mocysteinemia Is an Independent Risk Factor of Atherosclerosis in Patients with Metabolic Syndrome. Diabetology & Metabolic Syndrome, 11, Article No. 87.
https://doi.org/10.1186/s13098-019-0484-0
|
[14]
|
张帅. 炎性微环境靶向性纳米酶在动脉粥样硬化和缺血再灌注损伤治疗中的应用研究[D]: [博士学位论文]. 长春: 吉林大学, 2023.
|
[15]
|
王道鑫, 张添光, 缪朝玉. 血管内皮细胞线粒体氧化应激与动脉粥样硬化[J]. 药学实践与服务, 2023, 41(6): 329-334, 388.
|
[16]
|
Kattoor, A.J., Pothineni, N.V.K., Palagiri, D. and Mehta, J.L. (2017) Oxidative Stress in Atherosclerosis. Current Atherosclerosis Reports, 19, Article No. 42. https://doi.org/10.1007/s11883-017-0678-6
|
[17]
|
Marchio, P., Guerra-Ojeda, S., Vila, J.M., et al. (2019) Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 8563845.
https://doi.org/10.1155/2019/8563845
|
[18]
|
梁学飞, 马致远, 张永春, 等. SIRT1/LOX-1通路在同型半胱氨酸介导的动脉粥样硬化中作用的研究进展[J]. 医学综述, 2021, 27(8): 1487-1492.
|
[19]
|
殷玲. 高同型半胱氨酸血症与炎性反应疾病研究进展[J]. 国际检验医学杂志, 2020, 41(2): 228-232.
|
[20]
|
孙翔, 谭杰. 超声造影在检测冠心病颈动脉斑块内新生血管中的作用及与血清Hcy的关系[J]. 影像科学与光化学, 2022, 40(6): 1402-1406.
|
[21]
|
Jia, J., Wang, A., Wang, J., et al. (2016) Homocysteine and Its Relationship to Asympto-Matic Carotid Stenosis in a Chinese Community Population. Scientific Reports, 6, Article No. 37361. https://doi.org/10.1038/srep37361
|
[22]
|
孙文萍, 汤雪晴, 谢春香, 等. 同型半胱氨酸对血管内皮细胞核转录因子及细胞间黏附分子的影响[J]. 中华老年心脑血管病杂志, 2011, 13(6): 554-556.
|
[23]
|
Kones, R. (2011) Primary Prevention of Coronary Heart Disease: Integration of New Data, Evolving Views, Revised Goals, and Role of Rosuvastatin in Management. A Comprehensive Survey. Drug Design, Development and Therapy, 5, 325-380. https://doi.org/10.2147/DDDT.S14934
|
[24]
|
Eisenhardt, S.U., Ha-bersberger, J., Murphy, A., et al. (2009) Dissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques. Circulation Research, 105, 128-137.
https://doi.org/10.1161/CIRCRESAHA.108.190611
|
[25]
|
Georgakis, M.K., Malik, R., Richardson, T.G., et al. (2022) Associations of Genetically Predicted IL-6 Signaling with Cardiovascular Disease Risk across Population Sub-groups. BMC Medicine, 20, Article No. 245.
https://doi.org/10.1186/s12916-022-02446-6
|
[26]
|
Yuksel, B., Koc, P., Ozaydin Goksu, E., et al. (2021) Is Multiple Sclerosis a Risk Factor for Atherosclerosis? Journal of Neuroradiology, 48, 99-103. https://doi.org/10.1016/j.neurad.2019.10.002
|
[27]
|
Mayer, F.J., Binder, C.J., Wagner, O.F., et al. (2016) Combined Effects of Inflammatory Status and Carotid Atherosclerosis: A 12-Year Follow-Up Study. Stroke. 47, 2952-2958. https://doi.org/10.1161/STROKEAHA.116.013647
|
[28]
|
Zhang, Q., Wu, C., Liu, Y., et al. (2023) Chronic Inflam-mation Plays a Role of a Bridge between Cardiovascular Disease and Hyperglycemia. Metabolic Syndrome and Related Disorders, 21, 468-474.
https://doi.org/10.1089/met.2023.0086
|
[29]
|
Kadoglou, N.P.E., Moulakakis, K.G., Mantas, G., et al. (2022) The Association of Arterial Stiffness with Significant Carotid Atherosclerosis and Carotid Plaque Vulnerability. Angiology, 73, 668-674.
https://doi.org/10.1177/00033197211068936
|
[30]
|
Scimeca, M., Montanaro, M., Cardellini, M., et al. (2021) High Sensitivity C-Reactive Protein Increases the Risk of Carotid Plaque Instability in Male Dyslipidemic Patients. Diagnostics, 11, Article 2117.
https://doi.org/10.3390/diagnostics11112117
|
[31]
|
Shindo, A., Tanemura, H., Yata, K., et al. (20140 Inflammatory Biomarkers in Atherosclerosis: Pentraxin 3 Can Become a Novel Marker of Plaque Vulnerability. PLOS ONE, 9, e100045. https://doi.org/10.1371/journal.pone.0100045
|
[32]
|
Zhou, Y., Han, W., Gong, D., et al. (2016) Hs-CRP in Stroke: A Meta-Analysis. Clinica Chimica Acta, 453, 21-27.
https://doi.org/10.1016/j.cca.2015.11.027
|
[33]
|
樊蓉, 任卫东. 超声评估冠状动脉粥样硬化性心脏病患者二尖瓣环移位参数及其与血清Hcy、vWF及CysC水平的相关性研究[J]. 中国现代医学杂志, 2020, 30(13): 23-26.
|
[34]
|
Eriksson, P., Deguchi, H., Samnegård, A., et al. (2004) Human Evidence that the Cystatin C Gene Is Impli-cated in Focal Progression of Coronary Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 551-557.
https://doi.org/10.1161/01.ATV.0000117180.57731.36
|
[35]
|
Shi, G.P., Sukhova, G.K., Grubb, A., et al. (1999) Cystatin C Deficiency in Human Atherosclerosis and Aortic Aneurysms. Journal of Clinical Investigation, 104, 1191-1197. https://doi.org/10.1172/JCI7709
|
[36]
|
Cheng, X.W., Kuzuya, M., Sasaki, T., et al. (2004) Increased Expression of Elastolytic Cysteine Proteases, Cathepsins S and K, in the Neointima of Balloon-Injured Rat Carotid Ar-teries. The American Journal of Pathology, 164, 243-251.
https://doi.org/10.1016/S0002-9440(10)63114-8
|
[37]
|
Bengtsson, E., To, F., Håkansson, K., et al. (2005) Lack of the Cysteine Protease Inhibitor Cystatin C Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice. Arteriosclero-sis, Thrombosis, and Vascular Biology, 25, 2151-2156.
https://doi.org/10.1161/01.ATV.0000179600.34086.7d
|
[38]
|
Luo, F., Luo, J.Y., Liu, F., et al. (2023) Coronary Ar-tery Calcium and Cystatin C for Risk Stratification of MACCEs and All-Cause Death in Symptomatic Patients. Clinical Cardiology, 46, 195-203. https://doi.org/10.1002/clc.23959
|
[39]
|
Jasir, A., Kasprzykowski, F., Kasprzykowska, R., et al. (2003) New Antimicrobial CYSTATIN C-BASED PEPTIDE ACTive against Gram-Positive Bacterial Pathogens, Including Methicillin-Resistant Staphylococcus aureus and Multiresistant Coagulase-Negative Staphy-Lococci. APMIS, 111, 1004-1010.
https://doi.org/10.1111/j.1600-0463.2003.t01-1-apm1111110.x
|
[40]
|
Wu, H., Du, Q., Dai, Q., et al. (2018) Cyste-ine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases. Journal of Atherosclerosis and Thrombosis, 25, 111-123. https://doi.org/10.5551/jat.RV17016
|
[41]
|
Wang, X. and Khalil, R.A. (2018) Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease. Advances in Pharmacology, 81, 241-330. https://doi.org/10.1016/bs.apha.2017.08.002
|
[42]
|
Fraley, A.E. and Tsimikas, S. (2006) Clinical Applications of Circulating Oxidized Low-Density Lipoprotein Biomarkers in Cardiovascular Disease. Current Opinion in Lipidology, 17, 502-509.
https://doi.org/10.1097/01.mol.0000245255.40634.b5
|
[43]
|
Tsimikas, S., Lau, H.K., Han, K.R., et al. (2004) Per-cutaneous Coronary Intervention Results in Acute Increases in Oxidized Phospholipids and Lipoprotein (a): Short-Term and Long-Term Immunologic Responses to Oxidized Low-Density Lipoprotein. Circulation, 109, 3164-3170. https://doi.org/10.1161/01.CIR.0000130844.01174.55
|
[44]
|
舒瑛. 胱抑素C与心血管疾病的关系[J]. 心血管病学进展, 2010, 31(5): 673-677.
|
[45]
|
王群, 鹿庆华, 蒋卫东, 等. 胱抑素C对氧化型低密度脂蛋白诱导的人血管平滑肌细胞凋亡的影响[J]. 中国病理生理杂志, 2008, 24(12): 2319-2323.
|
[46]
|
Martinez, E., Martorell, J. and Riambau, V. (2020) Review of Serum Biomarkers in Carotid Atherosclerosis. Journal of Vascular Surgery, 71, 329-341. https://doi.org/10.1016/j.jvs.2019.04.488
|
[47]
|
梁蕴瑜, 谢平畅, 钟言, 等. 外周血HCY、PLR及hs-CRP预测原发性高血压患者颈动脉粥样硬化的诊断效能[J]. 现代生物医学进展, 2021, 21(16): 3110-3114.
|